Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Syncom Formulations India Ltd · Outcome · 13 Nov 2026, 10:16 pm
Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 14,214 (+16.8% YoY | +13.2% QoQ) ■ EBITDA: 3,193 (+73.5% YoY | +21.8% QoQ) ■ EBITDA Margin (%): 22.5 (+735 bps YoY | +159 bps QoQ) ■ PAT: 2,665 (+60.6% YoY | +7.3% QoQ) ■ EPS (INR): 0.28 (+55.6% YoY | +7.7% QoQ) Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Pharmaceuticals Drugs & Formulations ■ Revenue: 14,679 (+16.5% YoY | +11.0% QoQ) ■ EBIT: 3,518 (+65.0% YoY | +11.0% QoQ) ■ EBIT Margin (%): 24.0 (+705 bps YoY | -1 bps QoQ) Trading of Commodities ■ Revenue: 14.4 (-48.1% QoQ) ■ EBIT: 7.5 (+276.4% QoQ) ■ EBIT Margin (%): 51.9 (+4472 bps QoQ) Renting of Property ■ Revenue: 128 (+29.1% YoY | +51.6% QoQ) ■ EBIT: 118 (+19.8% YoY | +52.9% QoQ) ■ EBIT Margin (%): 92.8 (-717 bps YoY | +79 bps QoQ)
Original exchange filing (PDF)
More announcements from Syncom Formulations India Ltd
- Syncom Formulations (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Submission of standalone & Consolidated Unaudited Financial Results along with limited review report, statement of assets and liabilities and cash flow statements for the Quarter and Half .... · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 13 Nov 2026
- SYNCOM FORMULATIONS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to Regulation .... · 13 Nov 2026
- Corporate Announcement regarding approval and payment of final dividend. · 02 Oct 2026
- Disclosure under reg 30 of SEBI (LODR) reg 2015 read with sub clause 7 of para A of part A of schedule /// change in directorate. · 02 Oct 2026
- Outcome of 38th AGM · 02 Oct 2026
